| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/01/2006 | US20060116329 Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115542 Therapeutic delivery of carbon monoxide |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | DE19901687B4 Opioide Analgetika mit kontrollierter Wirkstofffreisetzung Opioid analgesics controlled release |
| 06/01/2006 | DE19849107B4 Verfahren zur Entfernung von unerwünschten, endogen vorhandenen toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A method for removing unwanted endogenously present toxic alkaloids from plants or herbal preparations |
| 06/01/2006 | DE102004057645A1 New substituted pteridine compounds, useful as phosphodiesterase 4 inhibitors for treating e.g. inflammatory diseases, cancer, asthma, ulcerative colitis, depression and schizophrenia |
| 06/01/2006 | DE102004057618A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/01/2006 | CA2590349A1 Potentiators of glutamate receptors |
| 06/01/2006 | CA2589561A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | CA2589460A1 New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 06/01/2006 | CA2589439A1 Modulators of muscarinic receptors |
| 06/01/2006 | CA2589289A1 Use of (-)-1-(benzofuran-2-yl)-2-propylaminopentane to treat substance dependence |
| 06/01/2006 | CA2588881A1 Potentiators of glutamate receptors |
| 06/01/2006 | CA2588812A1 Therapeutic pyrazolo[3,4-b] pyridines and indazoles |
| 06/01/2006 | CA2588597A1 Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury |
| 06/01/2006 | CA2588558A1 Jnk inhibitors for treatment of cns injury |
| 06/01/2006 | CA2587926A1 Bicyclic inhibitors or rho kinase |
| 06/01/2006 | CA2585857A1 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity |
| 06/01/2006 | CA2579962A1 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661898A1 Bicyclic piperazine compound and use thereof |
| 05/31/2006 | EP1661897A1 Pyrrolopyrimidinone derivative |
| 05/31/2006 | EP1661896A1 Pyrrolopyrimidinethione derivative |
| 05/31/2006 | EP1661887A1 Method for manufacture of sertindole |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1660506A2 Oral neurotherapeutic cefazolin compositions |
| 05/31/2006 | EP1660497A1 [ 1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660472A1 Aryl piperidine amides |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660461A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660434A1 Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition |
| 05/31/2006 | EP1660185A2 Treatment of stuttering and other communication disorders with norepinephrine reuptake inhibitors |
| 05/31/2006 | EP1660130A1 The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660082A1 Use of a compound in the treatment of sleep disorders |
| 05/31/2006 | EP1660071A1 Treatment of neurodegenerative conditions |
| 05/31/2006 | EP1660069A2 Neuroprotection protects against cellular apoptosis, neural stroke damage, alzheimer's disease and retinal degeneration |
| 05/31/2006 | EP1660065A2 Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors |
| 05/31/2006 | EP1660064A2 Treatment of learning disabilities and motor skills disorder with norepinephrine reuptake inhibitors |
| 05/31/2006 | EP1660063A1 Use of bicyclo [2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions |
| 05/31/2006 | EP1660046A1 Powder formulation comprising the cgrp antagonist 1- (n2-(3,5-dibromo-n-(4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)- 1-piperidinyl)carbonyl)-d-tyrosyl)-l-lysyl)-4-(4-pyridinyl)-piperazine |
| 05/31/2006 | EP1546123B1 Benzyl morpholine derivatives |
| 05/31/2006 | EP1487468B1 Plant extracts and the use thereof |
| 05/31/2006 | EP1467737B1 Orally dispersible pharmaceutical piribedil composition |
| 05/31/2006 | EP1453512B1 Acetylene derivatives having mglur 5 antagonistic activity |
| 05/31/2006 | EP1448181B1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 05/31/2006 | EP1446122B1 Use of flibanserin in the treatment of sexual desire disorders |
| 05/31/2006 | EP1401821A4 Novel phenylalkyl diamine and amide analogs |
| 05/31/2006 | EP1368336B1 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1346226B1 Screening method based on siah-numb interaction |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1263525B1 Method for preparing colloidal particles in the form of nanocapsules |
| 05/31/2006 | EP1263467B1 Paste formulations comprising silica |
| 05/31/2006 | EP1246789B1 Methods of making optically pure (r)- and (s)- didesmethylsibutramine |
| 05/31/2006 | EP1235851B1 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/31/2006 | EP1196183B1 Oregano-based therapeutic composition |
| 05/31/2006 | EP1121109B1 Biphasic tramadol preparation |
| 05/31/2006 | EP1112067B1 Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | CN1780855A Human IL-1 beta antagonists |
| 05/31/2006 | CN1780831A 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 05/31/2006 | CN1780829A Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 05/31/2006 | CN1780822A Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) |
| 05/31/2006 | CN1780820A Quinoxalinone-3- one derivatives as orexin receptor antagonists |
| 05/31/2006 | CN1780815A Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
| 05/31/2006 | CN1780664A Methods for treating sinus headache |
| 05/31/2006 | CN1780626A Treatment of bipolar disorders and associated symptoms |
| 05/31/2006 | CN1780623A PTEN inhibitor or MAXI-K channels opener |
| 05/31/2006 | CN1780622A 4-(2-phenylsulfanyl-phenyl)-piperidine derivates as serotonin reuptake inhibitors |
| 05/31/2006 | CN1780621A Sulfonamide derivatives as gamma secretase inhibitors. |
| 05/31/2006 | CN1780620A Use of a topical medicament comprising riluzole |
| 05/31/2006 | CN1780615A The use of azetidinecarboxamide derivatives in therapy. |
| 05/31/2006 | CN1780613A Methods of preventing,treating and diagnosing disorders of protein aggregation |
| 05/31/2006 | CN1780605A Opioid drug delivery system |
| 05/31/2006 | CN1778381A Chinese medicine for against depressive disorders and hypothermia |
| 05/31/2006 | CN1778371A Formula for treating wind-cold headache |
| 05/31/2006 | CN1778362A Formula for treating wind heat and headache |
| 05/31/2006 | CN1778300A Luotongding oral cavity disintegration tablet and preparation thereof |
| 05/31/2006 | CN1778299A Cavitas nasisal cavity medicine-supply preparation with radix aconiti agrestis methyl |
| 05/31/2006 | CN1778296A Long-acting preparation for tatin medicine |
| 05/31/2006 | CN1257908C Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 05/31/2006 | CN1257901C Tetrahydroquinoline ketopiperidine compounds and their preparation and use |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/31/2006 | CN1257747C Medicinal liquor for treating rheumatism |
| 05/31/2006 | CN1257743C Composite gastrodia luber medicine and its preparation and use |
| 05/31/2006 | CN1257737C Chinese traditional medicinal composition for treating hemicrania and its preparing process |
| 05/31/2006 | CN1257736C Sobering-up liver-protecting medicine composition for preventing chemical liver damage and its preparation process |
| 05/31/2006 | CN1257729C Medicine for treating headache and preparing method thereof |
| 05/31/2006 | CN1257719C Application of cnidium oil in preparing medicine for treating cerebral thrombus and headache |
| 05/30/2006 | USRE39113 Neuropathic pain; in humans, animals |
| 05/30/2006 | US7053245 N-acylamino benzyl ether derivatives |